نتائج البحث - "JP Vilque"

المؤلفون: Carras S; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Molecular biology department; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Oncohematology department., Torroja A; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Oncohematology department., Emadali A; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Research and innovation unit., Montaut E; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Research and innovation unit., Daguindau N; Hematology Department Annecy hospital., Tempescul A; Hematology Unit, Brest University Hospital, Brest France., Moreau A; Pathology Department, University Hospital, Nantes., Tchernonog E; Hematology Department, University Hospital, Montpellier., Schmitt A; Hematology Department, Cancerology Institute Bergonie, Bordeaux., Houot R; Hematology Department, University Hospital, Rennes., Dartigeas C; Hematology Department, University Hospital, Tours., Barbieux S; Hematology Department, Dunkerque Hospital., Corm S; Hematology Department, Chambery., Banos A; Hematology Department, Bayonne Cote Basque Hospital., Fouillet L; Hematology Department, University Hospital, Saint Etienne., Dupuis J; Lymphoid malignancies Unit, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Créteil., Macro M; IHBN - Hematology Department, University Hospital, Caen., Fleury J; Hematology Department, Cancerology Institute, Clermont-Ferrand., Jardin F; Hematology Department, Centre Henri Becquerel, Rouen., Sarkozy C; Institut Curie, Paris and Paris Saint Quentin University, UVSQ., Damaj G; Hematology Department, University Hospital, Caen., Feugier P; Hematology Department, University Hospital, Nancy., Fornecker LM; Hematology Department, University Hospital, Strasbourg., Chabrot C; Hematology Department, University Hospital, Clermont-Ferrand., Dorvaux V; Hematology Department, University Hospital, Metz., Bouabdallah K; Hematology Department, University Hospital, Bordeaux, Bordeaux., Amorim S; Hematology and cellular therapy Department, Hospital Saint Vincent de Paul, Université catholique de Lille., Garidi R; Hematology Department, Hospital Saint Quentin., Voillat L; Hematology Department, Hospital Chalon sur Saone., Joly B; Hematology Department, Corbeil Hospital., Morineau N; Hematology department, Hospital La Roche Sur Yon., Moles MP; Hematology Department, University Hospital Angers., Zerazhi H; Hematology Department, Avignon Hospital., Fontan J; Hematology Department, University Hospital, Besançon., Arkam Y; Hematology Department, Mulhouse Hospital., Alexis M; Hematology Department, Orleans Hospital., Delwail V; Onco-Hematology Department, University Hospital Poitiers and INSERM, CIC 1402, University of Poitiers., Vilque JP; Hematology Department, Cancer Center Baclesse Caen., Ysebaert L; Institut universitaire du cancer de Toulouse Oncopole., Burroni B; Assistance Publique - Hôpitaux de Paris (APHP), Hôpital Cochin, Department of Pathology; Centre de Recherche des Cordeliers, Sorbonne University, Inserm, UMRS 1138, Université Paris Cité, F-75006 Paris., Callanan M; Unit For Innovation in Genetics and Epigenetics and Oncology. Dijon University Hospital., Le Gouill S; Institut Curie, Paris and Paris Saint Quentin University, UVSQ., Gressin R; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Oncohematology department.

المصدر: Haematologica [Haematologica] 2024 Jun 01; Vol. 109 (6), pp. 1857-1865. Date of Electronic Publication: 2024 Jun 01.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Mantle-Cell*/drug therapy , Lymphoma, Mantle-Cell*/genetics , Lymphoma, Mantle-Cell*/mortality , Lymphoma, Mantle-Cell*/pathology , Tumor Suppressor Protein p53*/genetics , Mutation* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Hypoalbuminemia*/etiology, Humans ; Aged ; Female ; Male ; Aged, 80 and over ; Prognosis ; Rituximab/therapeutic use ; Rituximab/administration & dosage ; Treatment Outcome ; Bendamustine Hydrochloride/administration & dosage ; Bendamustine Hydrochloride/therapeutic use ; Dexamethasone/therapeutic use ; Dexamethasone/administration & dosage ; Doxorubicin/therapeutic use ; Doxorubicin/administration & dosage

Full Text Finder

10

دورية أكاديمية

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.

المؤلفون: Lübbert M; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany. Electronic address: michael.luebbert@uniklinik-freiburg.de., Wijermans PW; Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands., Kicinski M; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Chantepie S; Department of Hematology, Centre Hospitalo-Universitaire de Caen, Caen, France., Van der Velden WJFM; Department of Hematology, Radboud University, Nijmegen, Netherlands., Noppeney R; Klinik für Hämatologie und Stammzelltransplantation, University Hospital Essen, Essen, Germany., Griškevičius L; Department of Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania., Neubauer A; Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Gießen and Marburg, Campus Marburg, Marburg, Germany., Crysandt M; Department of Hematology, Oncology, Hemostasiology and Stem Cell Transplantation, Medical Clinic IV, University Hospital RWTH Aachen, Aachen, Germany., Vrhovac R; Department of Haematology, University Hospital Centre Zagreb, Zagreb, Croatia., Luppi M; Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, University of Modena and Reggio Emilia, Azienda Ospedaliera Universitaria, Modena, Italy., Fuhrmann S; Department of Hematology and Oncology, Helios Hospital Berlin-Buch, Kiel, Germany., Audisio E; Department of Haematology, Azienda Ospedaliera Città della Salute e della Scienza di Torino-Ospedale Molinette, Torino, Italy., Candoni A; Clinica Ematologica Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy., Legrand O; Service d'Hématologie Clinique et de Thérapie cellulaire, Hôpital Saint Antoine, APHP, Paris, France., Foà R; Ematologia, Dipartimento di Medicina Traslazionale e di Precisione, Sapienza Università di Roma, Rome, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., van Lammeren-Venema D; Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, Netherlands., Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, Netherlands., Giraut A; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Stevens-Kroef M; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Jansen JH; Laboratory Hematology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands., de Graaf AO; Laboratory Hematology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands., Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy., Ammatuna E; University Medical Center Groningen, Groningen, Netherlands., Vilque JP; Department of Hematology, Centre Hospitalo-Universitaire de Caen, Caen, France., Wäsch R; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany., Becker H; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany., Blijlevens N; Department of Hematology, Radboud University, Nijmegen, Netherlands., Dührsen U; Klinik für Hämatologie und Stammzelltransplantation, University Hospital Essen, Essen, Germany., Baron F; GIGA-I3 and Centre Hospitalier Universitaire, University of Liège, Liège, Belgium., Suciu S; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Amadori S; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Venditti A; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Huls G; University Medical Center Groningen, Groningen, Netherlands. Electronic address: g.huls@umcg.nl.

مؤلفون مشاركون: EORTC Leukemia Group, GIMEMA, and German MDS Study Group

المصدر: The Lancet. Haematology [Lancet Haematol] 2023 Nov; Vol. 10 (11), pp. e879-e889.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/diagnosis, Humans ; Middle Aged ; Aged ; Decitabine/therapeutic use ; Cytarabine/therapeutic use ; Daunorubicin/therapeutic use ; Transplantation, Homologous ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

View record from ScienceDirect

Full Text via ClinicalKey

Full Text Finder

تنقيح النتائج